Officially started on the 1st January 2021, the H2020 BRAINTEASER project launches today its operational activities. The project’s kick off meeting, organised in two days January 28thand 29th 2021, will gather together the project’s partners, a multidisciplinary gender-balanced consortium from academia, industry, clinical settings and the non-profit sector, active in six European Countries.
The BRAINTEASER project, that involves 11 partners and is led by the Universidad Politécnica de Madrid, will face the ambitious challenge of using Artificial Intelligence (AI) systems to process data gathered from patients affected by Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS) to make patients’ management more efficient and effective and to develop models able to predict the disease progression.
READ THE EVERYTHING @ EU INSIDER:
The BRAINTEASER project, bringing Artificial Intelligence home for a better care of amyotrophic lateral sclerosis and multiple sclerosis, kicked off!
BRAINTEASER has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No GA 101017598